Shandong Lukang Pharmaceutical Co.,Ltd. (SHSE: 600789)
Health Care · Pharmaceuticals · CN
CN¥8.28
+5.48% today · -16.3% 1Y
Shandong Lukang Pharmaceutical Co.,Ltd. (SHSE: 600789) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.29B and employs 6,469 people.
Over the last twelve months the share price has lost 16.3%, trading between 6.48 and 10.89.
Tweenvest scores Shandong Lukang Pharmaceutical Co.,Ltd. across four factors: quality 72/100, value 34/100, growth 74/100, dividend 50/100. Its strongest factor is growth.
600789 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.29B
- Revenue (TTM)
- $861.19M
- P/E
- 58.93
- EPS
- 0.14
- Dividend yield
- 0.60%
- Beta (5Y)
- 0.22
- 52-week high
- CN¥10.89
- 52-week low
- CN¥6.48
- Avg volume (3M)
- —
- Shares outstanding
- 1.05B
- Employees
- 6,469
- Next earnings
- —
About Shandong Lukang Pharmaceutical Co.,Ltd.
Shandong Lukang Pharmaceutical Co.,Ltd., a Chinese enterprise, primarily focuses on the production and distribution of bio-pharmaceuticals and antibiotics. Their comprehensive product range features active pharmaceutical ingredients (APIs) and finished drug formulations for both human and veterinary use, alongside bio-pesticides, traditional herbal remedies, and amino acids. Beyond its core pharmaceutical operations, the company also engages in environmental management services, including wastewater treatment, odor control, and the maintenance of sewage facilities, as well as the manufacturing and sale of ecological protection materials. Established in 1966 as Jining Antibiotic Factory, the firm rebranded to its current name in October 1993. Headquartered in Jining, China, it maintains a global footprint, distributing its offerings to approximately 40 nations across Asia, Europe, Africa, and the United States.
- ISIN
- CNE000000P61
- Founded
- 1966
- Listed since
- Feb 26, 1997
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Green Thumb Industries Inc.CNSX: GTII | $1.39B | CA$9.00 | -0.55% |
| Zhejiang Jolly Pharmaceutical Co.,LTDSZSE: 300181 | $1.38B | CN¥13.25 | +0.30% |
| Omeros CorporationNasdaqGM: OMER | $1.36B | $18.79 | +1.95% |
| Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.SHSE: 688076 | $1.32B | CN¥27.84 | -1.03% |
| CORONA Remedies LimitedNSEI: CORONA | $1.28B | Rs2,024.00 | -0.27% |
| Celltrion Pharm, Inc.KOSDAQ: A068760 | $1.28B | ₩38,800.00 | -3.24% |
| Zhejiang Xianju Pharmaceutical Co., Ltd.SZSE: 002332 | $1.27B | CN¥8.76 | +1.39% |
| Shandong Xinhua Pharmaceutical Company LimitedSEHK: 719 | $1.25B | HK$5.69 | -1.90% |
Figures last refreshed Oct 11, 2026.